Risk factors for relapse of chronic pulmonary aspergillosis after discontinuation of antifungal therapy
Clinical Infection in Practice · 2020-04 · 5 · 100015
DOI: 10.1016/j.clinpr.2020.100015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infection in Practice, 2020-04. Verfasst von Felix Bongomin und 5 weiteren Autor:innen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bongomin, F., Otu, A., Harris, C., Foden, P., Kosmidis, C., & Denning, D. W. (2020). Risk factors for relapse of chronic pulmonary aspergillosis after discontinuation of antifungal therapy. Clinical Infection in Practice, 5, 100015. https://doi.org/10.1016/j.clinpr.2020.100015
Vancouver
Bongomin F, Otu A, Harris C, Foden P, Kosmidis C, Denning DW. Risk factors for relapse of chronic pulmonary aspergillosis after discontinuation of antifungal therapy. Clinical Infection in Practice. 2020;5:100015. doi:10.1016/j.clinpr.2020.100015
BibTeX
@article{Bongomin2020,
author = {Bongomin, Felix and Otu, Akaninyene and Harris, Chris and Foden, Philip and Kosmidis, Chris and Denning, David W.},
title = {Risk factors for relapse of chronic pulmonary aspergillosis after discontinuation of antifungal therapy},
journal = {Clinical Infection in Practice},
year = {2020},
volume = {5},
pages = {100015},
doi = {10.1016/j.clinpr.2020.100015}
}
EUVIMED